Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report

T-cell prolymphocytic leukemia (T-PLL) is a rare aggressive disease with a poor prognosis. Allogeneic stem cell transplantation (allo-SCT) followed by alemtuzumab administration is the most promising treatment for T-PLL but is associated with a high risk of infections as alemtuzumab strongly suppres...

Descripción completa

Detalles Bibliográficos

Autores principales:	Naoki Okada, Ryusuke Yamamoto, Hayato Maruoka, Mayuko Himeno, Nobuhiro Hiramoto, Takayuki Ishikawa
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Karger Publishers 2023-08-01
Colección:	Case Reports in Oncology
Materias:	haploidentical stem cell transplantation post-transplant cyclophosphamide t-cell prolymphocytic leukemia alemtuzumab
Acceso en línea:	https://beta.karger.com/Article/FullText/531471
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!